TE
科技回声
首页24小时热榜最新最佳问答展示工作
GitHubTwitter
首页

科技回声

基于 Next.js 构建的科技新闻平台,提供全球科技新闻和讨论内容。

GitHubTwitter

首页

首页最新最佳问答展示工作

资源链接

HackerNews API原版 HackerNewsNext.js

© 2025 科技回声. 版权所有。

‘This is unprecedented’: Several private insurers won’t cover Biogen’s drug

2 点作者 tima101将近 4 年前

2 条评论

PragmaticPulp将近 4 年前
This is a good thing, IMO.<p>This is the drug that failed to show efficacy in trials but was approved anyway for reasons that no one can explain. There are investigations into how and why it was allowed to be approved.<p>It costs $56,000 per year and they can’t show that it has positive benefits, but the studies show it has significant side effects in some users.<p>It doesn’t make sense for insurance companies or the general public to shoulder the cost of $56,000 per year per potentially millions of patients to take a drug that can’t be proven to have any positive effect.<p>If someone has the means to afford this on their own and is willing to self-experiment them they can try, but they need to do it at their own cost.
dekhn将近 4 年前
Damn straight. If all providers don&#x27;t cover this it will force Biogen&#x27;s hand.